Carrington Reports Second Quarter 20...(s filings withthe Securities & Exchange ...)

CARRINGTON LABORATORIES, INC.

Condensed Consolidated Statements of Operations

(unaudited)

(in thousands, except per share amounts)

Three Months Ended Six Months Ended

June 30, June 30,

2007 2006 2007 2006

Revenue:

Medical Services $2,094 $2,112 $4,149 $4,223

Royalty income 104 104 209 208

Medical Services, total 2,198 2,216 4,358 4,431

Consumer Services 2,984 3,956 5,360 8,884

Grant income, DelSite 398 352 622 695

Total revenues 5,580 6,524 10,340 14,010

Cost and expenses:

Cost of product sales 4,105 5,043 7,990 10,643

Selling, general and

administrative 1,902 1,918 3,789 3,767

Research and development 97 162 307 366

Research and development-

DelSite 1,199 1,325 2,275 2,481

Other income (15) (9) (17) (17)

Interest expense, net 505 240 839 457

Net income (loss) before

income taxes (2,213) (2,155) (4,843) (3,687)

Provision for income

taxes - - - -

Net income (loss) $(2,213) $(2,155) $(4,843) $(3,687)

Net income (loss) per

common share -

basic and diluted $(0.20) $(0.20) $(0.44) $(0.34)

Weighted average shares

outstand
'/>"/>

SOURCE Carrington Laboratories, Inc. Copyright©2007 PR Newswire.

0 GOOD